Home › Funds › MPM BioImpact LLC › BIOA

MPM BioImpact LLC position in BIOA

BIOAGE LABS INC · Health Care

MPM BioImpact LLC reported holding 1,667,661 shares of BIOA (BIOAGE LABS INC) in its Q2 2026 13F filing — a position valued at US$40.9M, representing 2.49% of its reported portfolio and ranking #17 among its reported holdings. MPM BioImpact LLC first reported this position in Q2 2026.

Latest position (Q2 2026)1.67M sh
Reported value held$40.87M
Portfolio Weight2.49%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's BIOA position evolved

MPM BioImpact LLC first disclosed a stake in BIOA in Q2 2026 at 1,667,661 shares (US$40.9M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.67M $40.87M New

About BIOA and 13F data

BIOA (BIOAGE LABS INC) is a Health Care company. 78 other funds we track also report a position in BIOA — the largest reported positions include a16z Capital Management, L.L.C. (US$79.2M), Cormorant Asset Management, LP (US$58.6M), Sofinnova Investments, Inc. (US$56.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIOA

All BIOA fund holders →

FAQ

How long has MPM BioImpact LLC held BIOA?

MPM BioImpact LLC has disclosed BIOA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is MPM BioImpact LLC's current position in BIOA?

As of Q2 2026, MPM BioImpact LLC holds 1.67M shares of BIOA (BIOAGE LABS INC), valued at $40.87M, representing 2.49% of its reported portfolio and ranking #17.

Has MPM BioImpact LLC been buying or selling BIOA?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC newly opened its position in BIOA.

Which other funds hold BIOA?

Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Cormorant Asset Management, LP, Sofinnova Investments, Inc., among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.